Last update 25 May 2025

HLA-A2 Restricted Tumor Antigen Peptides(NCI)

Overview

Basic Info

Drug Type
Biological products
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication
Ependymoma
Inactive Indication-
Originator Organization
National Cancer InstituteNational Cancer Institute
Active Organization
University of PittsburghUniversity of Pittsburgh
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HLA-A2 Restricted Tumor Antigen Peptides(NCI)
NCT01795313
/ RecruitingPhase 1IIT
Immunotherapy for Recurrent Ependymomas in Children Using Human Leukocyte Antigen (HLA)-A2 Restricted Tumor Antigen Peptides in Combination with Imiquimod
100 Clinical Results associated with HLA-A2 Restricted Tumor Antigen Peptides(NCI)
Login to view more data
100 Translational Medicine associated with HLA-A2 Restricted Tumor Antigen Peptides(NCI)
Login to view more data
100 Patents (Medical) associated with HLA-A2 Restricted Tumor Antigen Peptides(NCI)
Login to view more data
100 Deals associated with HLA-A2 Restricted Tumor Antigen Peptides(NCI)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EpendymomaPhase 1
United States
University of PittsburghUniversity of Pittsburgh
01 Aug 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free